Chemrx Advanced Technologies Inc was acquired by Infinity Pharmaceuticals, Inc. Formerly know as as SIDDCO, Chemrx Advanced Technologies Inc ( A subsidiary of Discovery Partners International Inc) the firm is a privately held BioHighTech company developing, integrated new enabling technologies into drug discovery to reduce drug development time and improve success. Enabling technologies include: (i) combinatorial chemistry to rapidly synthesize thousands to millions of new compounds that have potential value as pharmaceuticals, (ii) High Density Miniaturized Screening (HDMS) for testing 100,000Ãs of compounds per day, and (iii) Multi-Array Plate Screening (MAPS), a proprietary Ãgene-to-screenà technology which permits simultaneous screening of many targets. These technologies provide clients novel chemical compounds from which to identify hits, streamlined combinatorial medicinal chemistry optimization of leads, and unique and information rich bioassays that maximize the number of drug discovery screens, minimizing time to start the screening process, and enable efficacy, specificity, and safety to be assessed and optimized simultaneousl